HDHD2 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 4.312600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.390600E-01
Normal-vs-Stage2
8.396100E-02
Normal-vs-Stage3
9.194200E-02
Normal-vs-Stage4
2.524800E-01
Stage1-vs-Stage2
1.268410E-01
Stage1-vs-Stage3
1.176370E-01
Stage1-vs-Stage4
2.448600E-01
Stage2-vs-Stage3
4.332800E-01
Stage2-vs-Stage4
8.293800E-01
Stage3-vs-Stage4
4.937400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
4.901600E-01
Normal-vs-AfricanAmerican
1.372410E-01
Normal-vs-Asian
7.521700E-03
Caucasian-vs-AfricanAmerican
7.864800E-01
Caucasian-vs-Asian
2.598900E-03
AfricanAmerican-vs-Asian
6.394400E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.936800E-01
Normal-vs-Female
4.939400E-01
Male-vs-Female
4.930600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
8.073200E-01
Normal-vs-Age(41-60Yrs)
6.256800E-01
Normal-vs-Age(61-80Yrs)
3.515400E-01
Normal-vs-Age(81-100Yrs)
7.492100E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.978000E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
1.855650E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
4.489600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
1.709620E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
1.459440E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
6.992600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
2.781700E-02
Normal-vs-Daily Drinker
3.015000E-01
Normal-vs-Weekly Drinker
1.479910E-02
Normal-vs-Occasional Drinker
9.096000E-01
Normal-vs-Social Drinker
7.704800E-01
Non Drinker-vs-Daily Drinker
8.287200E-01
Non Drinker-vs-Weekly Drinker
3.670800E-01
Non Drinker-vs-Occasional Drinker
1.522980E-01
Non Drinker-vs-Social Drinker
2.807600E-01
Daily Drinker-vs-Weekly Drinker
4.411000E-01
Daily Drinker-vs-Occasional Drinker
2.354600E-01
Daily Drinker-vs-Social Drinker
3.536200E-01
Weekly Drinker-vs-Occasional Drinker
8.424300E-02
Weekly Drinker-vs-Social Drinker
1.636640E-01
Occasional Drinker-vs-Social Drinker
7.852800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
2.738000E-01
Normal-vs-Grade 2
2.373800E-01
Normal-vs-Grade 3
1.807600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
5.435200E-03
Grade 1-vs-Grade 3
7.116800E-03
Grade 1-vs-Grade 4
2.738000E-01
Grade 2-vs-Grade 3
7.580200E-01
Grade 2-vs-Grade 4
2.373800E-01
Grade 3-vs-Grade 4
1.807600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.760970E-01
Normal-vs-NonDiabetic
4.962200E-01
Diabetic-vs-NonDiabetic
2.703000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
1.941700E-03
Normal-vs-NoPancreatitis
4.588800E-01
Pancreatitis-vs-NoPancreatitis
2.717300E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
7.675600E-01
Normal-vs-N1
1.112760E-01
N0-vs-N1
1.410570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
5.404500E-03
Normal-vs-TP53-NonMutant
9.542200E-01
TP53-Mutant-vs-TP53-NonMutant
1.43659999995993E-06
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
